Industry / Ukraine

Darnytsa Under Threat

November 2007 | Industry News

Printable version
Bookmark

Corruption is continuing to taint the pharmaceutical sector in the CIS, after further reports surfaced concerning illegal takeovers in the Ukraine. Earlier this year,

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

High Growth But Risks To Outlook

Industry / Ukraine BMI View: Our view that Ukraine's pharmaceutical market will continue to see strong-double-digit growth into 2011 have now been confirmed. Supported by a return to economic growth, we maintain our view...

May 2011

Pharmaceutical Association Emphasise Market Risks

Industry / Ukraine BMI View: Our view that Ukraine is a highly rewarding but ultimately risk prone pharmaceutical market has been partially validated by the Ukrainian Association of Pharmaceutical Research and Development...

April 2011

Hospital Sales Detract From Market Growth

Industry / Ukraine BMI View: It is clear that the financial burden of medicines in Ukraine continues to be shifted from public funds to out-of-pocket spending. While BMI highlights the increasingly difficult hospital segment,...

March 2011

Hospital Sales Detract From Market Growth

March 2011

Downside Risks With Medicine Advertising Ban But Growth To Remain

Industry / Ukraine BMI View: It is beyond question that the level of drug consumption and the choice of pharmaceuticals purchased in Ukraine are substantially affected by the sector's high level of advertising. While BMI...

February 2011